Stock Events

Stock Events

Tscan Therapeutics (TCRX) Q1 2026 Earnings

4MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.33

-0.28

-0.23

-0.18

Details

Expected EPS

-0.270267

Actual EPS

-0.18

Surprise EPS

0.09

Surprise Percent

+33.4%

Description

Tscan Therapeutics (TCRX) has reported earnings of -0.18 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.